Rare Disease Drug Market Report

Global and China Rare Disease Drug Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 01, 2022
  • PAGES：228
  • REPORT CODE：GMM1333083
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Rare disease drugs refer to the drugs that are used for rare diseases or have little commercial value, and no pharmaceutical company is willing to invest in the development of drugs. The definition of rare diseases is defined as 5/10000 of patients with less than 200 thousand patients or less than the incidence rate. There are 5000-6000 kinds of rare diseases, accounting for about 10% of human diseases.

    With the COVID-19 outbreak in 2019, the global economy has been hit hard to some extent, but the health sector has been less affected. According to the forecast, the Rare Disease Drug market will maintain steady market growth over the forecast period and eventually achieve a compound annual growth rate of 11.5%.

    The government has been instrumental in the development of the market for Rare Disease Drug. First, the government collects a smaller tax on companies that produce or research Rare Disease Drug. Second, the government has legally given more licenses to the production of Rare Disease Drug. These are all positive drivers of the global market for Rare Disease Drug.

    This report elaborates on the current development of the Rare Disease Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Deciphera

    • Atara Biotherapeutics

    • Pfizer, Inc

    • Novo Nordisk A/S

    • Amgen, Inc

    • Sanofi SA

    • Eli Lilly and Company

    • Eisai Co, Ltd

    • Daiichi Sankyo Company Limited

    • Alexion Pharmaceuticals, Inc

    • Bayer AG

    • GlaxoSmithKline

    • ProQR

    • Merck & Co, Inc

    • Celgene Corporation

    • Bristol-Myers Squibb Company

    • Biogen, Inc

    • Shire

    • Novartis AG

    • AstraZeneca

    • Johnson & Johnson

    • F Hoffmann-La Roche Ltd

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • >1%

    • 065%~1%

    • <01%

    Application:

    • Hospital Pharmacies

    • Speciality Pharmacies

    • Retail pharmacies

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Rare Disease Drug Industry Overview

      • 1.1.1 Rare Disease Drug Market Scope and Market Segments

      • 1.1.2 Rare Disease Drug Industry Characteristics

      • 1.1.3 Global and China Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Rare Disease Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global Rare Disease Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 >1%

      • 1.2.2 065%~1%

      • 1.2.3 <01%

    • 1.3 Global Rare Disease Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Speciality Pharmacies

      • 1.3.3 Retail pharmacies

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Rare Disease Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Rare Disease Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Rare Disease Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Rare Disease Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Rare Disease Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Rare Disease Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Rare Disease Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Rare Disease Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Rare Disease Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Rare Disease Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 Rare Disease Drug Industry PEST Analysis

    • 2.3 Rare Disease Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Rare Disease Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Rare Disease Drug Industry

    Chapter 3 Global and China Rare Disease Drug Market, by Manufacturer

    • 3.1 Global and China Rare Disease Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Rare Disease Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Rare Disease Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Rare Disease Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Rare Disease Drug Market Top 3 Players

    Chapter 4 Global and China Rare Disease Drug Market, by Type (2017-2028)

    • 4.1 Rare Disease Drug Market Trend, by Type

    • 4.2 Global Rare Disease Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Rare Disease Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Rare Disease Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Rare Disease Drug Price Trend, by Type (2017-2028)

    • 4.3 China Rare Disease Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Rare Disease Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Rare Disease Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Rare Disease Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Rare Disease Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Rare Disease Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Rare Disease Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Rare Disease Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Rare Disease Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Rare Disease Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Rare Disease Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Rare Disease Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Rare Disease Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Rare Disease Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Rare Disease Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Rare Disease Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Rare Disease Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Rare Disease Drug Market Analysis

    • 7.1 North America Rare Disease Drug Market, by Type

    • 7.2 North America Rare Disease Drug Market, by Application

    • 7.3 North America Rare Disease Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Rare Disease Drug Market Analysis

    • 8.1 Europe Rare Disease Drug Market, by Type

    • 8.2 Europe Rare Disease Drug Market, by Application

    • 8.3 Europe Rare Disease Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Rare Disease Drug Market Analysis

    • 9.1 APAC Rare Disease Drug Market, by Type

    • 9.2 APAC Rare Disease Drug Market, by Application

    • 9.3 APAC Rare Disease Drug Market Analysis and Forecast, by Country

      • 9.3.1 China Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Rare Disease Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa Rare Disease Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa Rare Disease Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa Rare Disease Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Rare Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Rare Disease Drug Company Profiles

      • 11.1 Deciphera

        • 11.1.1 Deciphera Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Deciphera Rare Disease Drug Product Profiles, Application and Specification

        • 11.1.3 Deciphera Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Atara Biotherapeutics

        • 11.2.1 Atara Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Atara Biotherapeutics Rare Disease Drug Product Profiles, Application and Specification

        • 11.2.3 Atara Biotherapeutics Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Pfizer, Inc

        • 11.3.1 Pfizer, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Pfizer, Inc Rare Disease Drug Product Profiles, Application and Specification

        • 11.3.3 Pfizer, Inc Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Novo Nordisk A/S

        • 11.4.1 Novo Nordisk A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Novo Nordisk A/S Rare Disease Drug Product Profiles, Application and Specification

        • 11.4.3 Novo Nordisk A/S Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Amgen, Inc

        • 11.5.1 Amgen, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Amgen, Inc Rare Disease Drug Product Profiles, Application and Specification

        • 11.5.3 Amgen, Inc Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Sanofi SA

        • 11.6.1 Sanofi SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Sanofi SA Rare Disease Drug Product Profiles, Application and Specification

        • 11.6.3 Sanofi SA Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Eli Lilly and Company

        • 11.7.1 Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Eli Lilly and Company Rare Disease Drug Product Profiles, Application and Specification

        • 11.7.3 Eli Lilly and Company Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Eisai Co, Ltd

        • 11.8.1 Eisai Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Eisai Co, Ltd Rare Disease Drug Product Profiles, Application and Specification

        • 11.8.3 Eisai Co, Ltd Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Daiichi Sankyo Company Limited

        • 11.9.1 Daiichi Sankyo Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Daiichi Sankyo Company Limited Rare Disease Drug Product Profiles, Application and Specification

        • 11.9.3 Daiichi Sankyo Company Limited Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Alexion Pharmaceuticals, Inc

        • 11.10.1 Alexion Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Alexion Pharmaceuticals, Inc Rare Disease Drug Product Profiles, Application and Specification

        • 11.10.3 Alexion Pharmaceuticals, Inc Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Bayer AG

        • 11.11.1 Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Bayer AG Rare Disease Drug Product Profiles, Application and Specification

        • 11.11.3 Bayer AG Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 GlaxoSmithKline

        • 11.12.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 GlaxoSmithKline Rare Disease Drug Product Profiles, Application and Specification

        • 11.12.3 GlaxoSmithKline Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 ProQR

        • 11.13.1 ProQR Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 ProQR Rare Disease Drug Product Profiles, Application and Specification

        • 11.13.3 ProQR Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Merck & Co, Inc

        • 11.14.1 Merck & Co, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Merck & Co, Inc Rare Disease Drug Product Profiles, Application and Specification

        • 11.14.3 Merck & Co, Inc Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Celgene Corporation

        • 11.15.1 Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Celgene Corporation Rare Disease Drug Product Profiles, Application and Specification

        • 11.15.3 Celgene Corporation Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Bristol-Myers Squibb Company

        • 11.16.1 Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Bristol-Myers Squibb Company Rare Disease Drug Product Profiles, Application and Specification

        • 11.16.3 Bristol-Myers Squibb Company Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Biogen, Inc

        • 11.17.1 Biogen, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Biogen, Inc Rare Disease Drug Product Profiles, Application and Specification

        • 11.17.3 Biogen, Inc Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Shire

        • 11.18.1 Shire Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Shire Rare Disease Drug Product Profiles, Application and Specification

        • 11.18.3 Shire Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Novartis AG

        • 11.19.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Novartis AG Rare Disease Drug Product Profiles, Application and Specification

        • 11.19.3 Novartis AG Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 AstraZeneca

        • 11.20.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 AstraZeneca Rare Disease Drug Product Profiles, Application and Specification

        • 11.20.3 AstraZeneca Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Johnson & Johnson

        • 11.21.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Johnson & Johnson Rare Disease Drug Product Profiles, Application and Specification

        • 11.21.3 Johnson & Johnson Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 F Hoffmann-La Roche Ltd

        • 11.22.1 F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 F Hoffmann-La Roche Ltd Rare Disease Drug Product Profiles, Application and Specification

        • 11.22.3 F Hoffmann-La Roche Ltd Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Rare Disease Drug Industry Investment Prospect and Risk Assessment

    • 12.1 Rare Disease Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Rare Disease Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global Rare Disease Drug Production Value and Growth Rate (2017-2028)

    • Figure China Rare Disease Drug Production Value and Growth Rate (2017-2028)

    • Figure Global Rare Disease Drug Market Size and Growth Rate of >1% (2017-2028)

    • Figure Global Rare Disease Drug Market Size and Growth Rate of 065%~1% (2017-2028)

    • Figure Global Rare Disease Drug Market Size and Growth Rate of <01% (2017-2028)

    • Figure Global Rare Disease Drug Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Rare Disease Drug Market Size and Growth Rate of Speciality Pharmacies (2017-2028)

    • Figure Global Rare Disease Drug Market Size and Growth Rate of Retail pharmacies (2017-2028)

    • Figure Global Rare Disease Drug Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Rare Disease Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Rare Disease Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Rare Disease Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Rare Disease Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Rare Disease Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Rare Disease Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Rare Disease Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Rare Disease Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Rare Disease Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Rare Disease Drug Market Share, by Manufacturer in 2021

    • Figure Global and China Rare Disease Drug Market Share, by Manufacturer in 2022

    • Table Global Rare Disease Drug Sales Volume, by Type (2017-2028)

    • Table Global Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table Global Rare Disease Drug Sales Value, by Type (2017-2028)

    • Table Global Rare Disease Drug Sales Value Share, by Type (2017-2028)

    • Figure Global Rare Disease Drug Price Trend, by Type (2017-2028)

    • Table China Rare Disease Drug Sales Volume, by Type (2017-2028)

    • Table China Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure China Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table China Rare Disease Drug Sales Value, by Type (2017-2028)

    • Table China Rare Disease Drug Sales Value Share, by Type (2017-2028)

    • Figure China Rare Disease Drug Price Trend, by Type (2017-2028)

    • Table Global Rare Disease Drug Sales Volume, by Application (2017-2028)

    • Table Global Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Table Global Rare Disease Drug Sales Value, by Application (2017-2028)

    • Table Global Rare Disease Drug Sales Value Share, by Application (2017-2028)

    • Figure Global Rare Disease Drug Sales Value Share, by Application (2017-2028)

    • Table China Rare Disease Drug Sales Volume, by Application (2017-2028)

    • Table China Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Table China Rare Disease Drug Sales Value, by Application (2017-2028)

    • Table China Rare Disease Drug Sales Value Share, by Application (2017-2028)

    • Figure China Rare Disease Drug Sales Value Share, by Application (2017-2028)

    • Figure China Rare Disease Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America Rare Disease Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Rare Disease Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Rare Disease Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Rare Disease Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America Rare Disease Drug Sales Volume, by Type (2017-2028)

    • Table North America Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table North America Rare Disease Drug Sales Volume, by Application (2017-2028)

    • Table North America Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe Rare Disease Drug Sales Volume, by Type (2017-2028)

    • Table Europe Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe Rare Disease Drug Sales Volume, by Application (2017-2028)

    • Table Europe Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure France Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC Rare Disease Drug Sales Volume, by Type (2017-2028)

    • Table APAC Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC Rare Disease Drug Sales Volume, by Application (2017-2028)

    • Table APAC Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure India Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Rare Disease Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Rare Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Rare Disease Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Rare Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Rare Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Rare Disease Drug Sales Value and Growth Rate (2017-2028)

    • Table Deciphera Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Deciphera Product Profiles, Application and Specification

    • Table Deciphera Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Atara Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Atara Biotherapeutics Product Profiles, Application and Specification

    • Table Atara Biotherapeutics Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer, Inc Product Profiles, Application and Specification

    • Table Pfizer, Inc Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novo Nordisk A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novo Nordisk A/S Product Profiles, Application and Specification

    • Table Novo Nordisk A/S Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen, Inc Product Profiles, Application and Specification

    • Table Amgen, Inc Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi SA Product Profiles, Application and Specification

    • Table Sanofi SA Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly and Company Product Profiles, Application and Specification

    • Table Eli Lilly and Company Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eisai Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eisai Co, Ltd Product Profiles, Application and Specification

    • Table Eisai Co, Ltd Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Daiichi Sankyo Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Daiichi Sankyo Company Limited Product Profiles, Application and Specification

    • Table Daiichi Sankyo Company Limited Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alexion Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alexion Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Alexion Pharmaceuticals, Inc Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer AG Product Profiles, Application and Specification

    • Table Bayer AG Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ProQR Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ProQR Product Profiles, Application and Specification

    • Table ProQR Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck & Co, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck & Co, Inc Product Profiles, Application and Specification

    • Table Merck & Co, Inc Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celgene Corporation Product Profiles, Application and Specification

    • Table Celgene Corporation Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Company Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Company Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biogen, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biogen, Inc Product Profiles, Application and Specification

    • Table Biogen, Inc Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shire Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shire Product Profiles, Application and Specification

    • Table Shire Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Ltd Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Ltd Rare Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US